Reportlinker finds all market research
reports published by official sources!

Investor presentation: Pathology for Year 2011

  • This 27-page company report was published in March 2011.
... as well as 32 967 Pathology industry reports, company profiles and country guides published by official sources (government, embassies, trade unions...).

We value your privacy and will never rent or sell your email address. Privacy Policy by TRUSTe

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

Talk to Sam

+1 718 473 0872

Share


Pathology Industry : Latest Downloads

Company Report: Pathology for Year 2014

  • Company report
  • April 2014
  • 6 pages

... For ampyra in stroke, the adaptive design of the phase 2/3 trial should allow acorda to take an interim look at efficacy as measured by 2-min walk distance as well as a scaled efficacy measurement similar ...

Company Report: Cancer for Year 2014

  • Company report
  • April 2014
  • 2 pages

... Personalized therapeutics for patients with genetically defined cancers. Epizyme has built a proprietary product platform that the company uses to create small molecule inhibitors of a 96-member class ...

Astellas Pharma Inc. - Company Report for Year 2014

  • Company report
  • February 2014
  • 32 pages


Pathology Industry : Latest Reports

Nonmelanomatous Skin Cancer - Pipeline Review, H2 2013

Nonmelanomatous Skin Cancer - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • December 2013
  • by Global Markets Direct

Nonmelanomatous Skin Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Nonmelanomatous Skin Cancer - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. ...

Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H2 2013

Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • December 2013
  • by Global Markets Direct

Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H2 2013', provides an overview ...

Germ Cell Tumors - Pipeline Review, H2 2013

Germ Cell Tumors - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • December 2013
  • by Global Markets Direct

Germ Cell Tumors - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Germ Cell Tumors - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides ...


ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.